FTC Wins Dismissal Of Opana, Lidoderm Pay-For-Delay Suit

By Eric Kroh ( November 8, 2016, 6:12 PM EST) -- A Pennsylvania federal judge granted the U. S. Federal Trade Commission's request to dismiss its pay-for-delay suit against Endo Pharmaceuticals Inc. over pain drugs Opana ER and Lidoderm on Tuesday after Endo succeeded in splitting the case in two. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login